Category Archives: Cancer and neoplasms
Cancer and neoplasms
What We’re Reading: Telemedicine Abortions Surge; Minor Gender-Affirming Treatment Ban; Children Lose Medicaid
Aug
Iowa Sees Surge in Telemedicine Abortions Amid Legal Battle The use of telemedicine for abortions in Iowa—which involves a health center visit for the first of a 2-pill medication regimen and taking the second pill at home—has experienced substantial growth, increasing by more than 10% from April 2022 to March 2023, according to Axios. This […]
Cancer and neoplasms
FDA Approves Luspatercept as First-Line Anemia Treatment in Patients With Lower-Risk MDS
Aug
The FDA has approved luspatercept (Reblozl) for the treatment of anemia in patients with lower-risk myelodysplastic syndromes (MDS) who may need red blood cell (RBC) transfusions and are naïve to erythropoiesis-stimulating agents (ESAs).1 The approval was supported by data from the COMMANDS study, a global phase 3 trial in which 58.5% (n = 86) of […]
Cancer and neoplasms
Study Examines Sun Protection Habits in Sexual and Gender Minority Populations in Lebanon
Aug
By surveying sun damage perceptions among sexual and gender minority populations in Lebanon, investigators hoped to initiate conversations about contributing risk factors for skin cancers, according to a recent cross-sectional study1 published in the Journey of Cosmetic Dermatology. Nattawat/Adobe Stock According to study authors Ghaoui et al, previous research has shown that men who are […]
Aug
Introduction Percutaneous biopsies are increasingly being utilized in patients with renal masses. Renal mass biopsy aids in reducing unnecessary interventions and has been proven to be a safe diagnostic tool.1–4 Previous observations from large centers, such as the Memorial Sloan–Kettering Cancer Center, have shown a strong correlation between the risk of malignancy and high-grade tumors, […]
Cancer and neoplasms
Performance of different colorectal cancer screening strategies: a long-term passive follow-up population-based screening program in Beijing, China
Aug
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. Article PubMed Google Scholar Zheng RS, Zhang SW, Zeng HM, Wang SM, Sun KX, Chen R, et al. Cancer […]
Cancer and neoplasms
Biliary Tract Cancer Market to Register Stunning Growth by 2032, Examines DelveInsight | Key Companies to Watch Out – Merck, AstraZeneca, Taiho Oncology, Basilea, Eisai, Zymeworks, BeiGene, Xencor, BMS, Leap
Aug
New York, USA, Aug. 28, 2023 (GLOBE NEWSWIRE) — Biliary Tract Cancer Market to Register Stunning Growth by 2032, Examines DelveInsight | Key Companies to Watch Out – Merck, AstraZeneca, Taiho Oncology, Basilea, Eisai, Zymeworks, BeiGene, Xencor, BMS, Leap The biliary tract cancer market is expected to grow significantly owing to an increase in upcoming […]
Cancer and neoplasms
Prophylactic use amphotericin B use in patients with hematologic disorders complicated by neutropenia: a systematic review and meta-analysis
Aug
Abstract The purpose of this study is to evaluate the efficacy of prophylactic use amphotericin B in patients with hematologic disorders complicated by neutropenia. We searched the PubMed, EMBASE, The Cochrane Library, CBM, CNKI, VIP and WanFang Data database and the China Clinical Trials Registry (www.chictr.org.cn) to collect randomized controlled trials (RCTs) of amphotericin B […]
Aug
Marina Kremyanskaya, MD, PhD, assistant professor, medicine, hematology, and medical oncology, Icahn School of Medicine, Mount Sinai, medical director, Inpatient Oncology Unit, The Mount Sinai Hospital, discusses the safety profile and future implications of rusfertide (PTG-300) in the treatment of patients with phlebotomy-dependent polycythemia vera (PV), as seen in the phase 2 REVIVE trial (NCT04057040). […]